4-Bromobutyl acetate | CAS:4753-59-7

We serve 4-Bromobutyl acetate CAS:4753-59-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Bromobutyl acetate

Chemical Name:4-Bromobutyl acetate
CAS.NO:4753-59-7
Synonyms:4-Bromobutyl acetate
4-acetoxy-butylbromide
acetic 4-bromo-butyl ester
1-acetoxy-4-bromobutane
4-bromo-1-acetoxybutane
Molecular Formula:C6H11BrO2
Molecular Weight:195.05400
 
Physical and Chemical Properties:
Density:1.348
Boiling point:92-93ºC
Flash point:229°F
Index of Refraction:1.46
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 4-Bromobutyl acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-bromo-1-acetoxybutane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromobutyl acetate Use and application,4-Bromobutyl acetate technical grade,usp/ep/jp grade.


Related News: “The number of confirmed cases of coronavirus in Taiwan is not higher than in most countries affected,” Mr. Wu said. “Other than China, no other country, no other country has had its flight banned by Italy.”Ethyl 3-(isopropylamino)propanoate manufacturer “The number of confirmed cases of coronavirus in Taiwan is not higher than in most countries affected,” Mr. Wu said. “Other than China, no other country, no other country has had its flight banned by Italy.”4'-Aminobenzanilide supplier “The number of confirmed cases of coronavirus in Taiwan is not higher than in most countries affected,” Mr. Wu said. “Other than China, no other country, no other country has had its flight banned by Italy.”(2R,3S)-N-Boc-3-Phenylisoserine vendor By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.